The table below provides, for the periods indicated, information pertaining to the calculation of earnings per share, common stock equivalents, weighted-average number of antidilutive options and restricted stock units, and shares issued (amounts in thousands):


	Three months ended July 31,				Nine months ended July 31,
	2026		2025		2026		2025
Numerator:
Net income as reported	$	280,145	$	369,621	$	751,668	$	899,771

Denominator:
Basic weighted-average shares	93,897		98,434		94,914		99,718
Common stock equivalents (1)	548		736		654		811
Diluted weighted-average shares	94,445		99,170		95,568		100,529

Other information:

Weighted-average number of antidilutive options and restricted stock units (2)	2		5		51		86
Shares issued under stock incentive and employee stock purchase plans	118		21		526		399

(1) Common stock equivalents represent the dilutive effect of outstanding in-the-money stock options using the treasury stock method and shares expected to be issued upon the conversion of restricted stock units under our equity award programs.

(2) Weighted-average number of antidilutive options and restricted stock units are based upon the average closing price of our common stock on the New York Stock Exchange for the period.